Immunocorrective treatment use in the prevention of hematological and infectious complications of chemotherapy in cancer patients

Immunocorrective treatment use in the prevention of hematological and infectious complications of chemotherapy in cancer patients

The article analyzes the use of immunocorrection of hematological toxicity that occurs during chemotherapy in cancer patients. Hematological toxicity, along with cardiotoxicity and hepatotoxicity often prevents the implementation of the entire planned volume of chemotherapy.Standard therapy (colony...

Full description

Bibliographic Details
Main Authors:	L. Yu. Grivtsova, V. B. Larionova, N. A. Falaleeva
Format:	Article
Language:	Russian
Published:	ABV-press 2021-11-01
Series:	Онкогематология
Subjects:	oncology chemotherapy hematological toxicity febrile neutropenia supportive care immunocorrection infectious complication
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/501

Similar Items

Chemotherapy-related infectious complications in patients with Hematologic malignancies
by: Raluca Ana Rusu, et al.
Published: (2018-01-01)

Infectious complications in patients with acute leukemia according to the duration of neutropenia
by: V. A. Okhmat, et al.
Published: (2018-10-01)

Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer
by: Hongyuan Jia, et al.
Published: (2024-08-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
by: Agus Suryaman
Published: (2024-12-01)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
by: Aikaterini Voulgaridou, et al.
Published: (2020-08-01)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021-04-01)

INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL
by: V. A. Okhmat, et al.
Published: (2017-10-01)

Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
by: Eun Young Nam, et al.
Published: (2016-03-01)

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

Effect of an education program on knowledge, self-care behavior and handwashing competence on prevention of febrile neutropenia among breast cancer patients receiving Doxorubicin and Cyclophosphamide in Chemotherapy Day Centre
by: Wai Chi Mak, et al.
Published: (2015-01-01)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021-11-01)

Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
by: Yoshitaka Ono, et al.
Published: (2022-12-01)

Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
by: Razan Zatarah, et al.
Published: (2022-10-01)

EXPRESSION OF IMMUNOCORRECTIVE EFFECTS OF PHENOTROPIL AT DIFFERENT TERMS OF INDUCED IMMUNOSUPPRESSION
by: M. A. Samotrueva, et al.
Published: (2014-07-01)

EFFECTS OF IMMUNOCORRECTION ON THE STATE OF CYTOKINES AND SLPI IN PATIENTS WITH PYELONEPHRITIS
by: M. Kolesnyк, et al.
Published: (2014-01-01)

ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE
by: R. V. Maiorov, et al.
Published: (2015-03-01)

Discussion Questions of Immunocorrection in Сhildren with Recurrent Respiratory Infections
by: Ye.D. Duka
Published: (2013-10-01)

Utilidad de la procalcitonina en pacientes adultos con neoplasias hematológicas y neutropenia febril posquimioterapia: Estado del arte Usefulness of procalcitonin in the management of adult patients with hematological malignancies with fever and chemotherapy-induced neutropenia: State of the art
by: Diego Andrés Bonilla, et al.
Published: (2012-12-01)

Optimization of complex treatment of aggressive peri-odontitis using immunocorrecting therapy
by: Vedyaeva A.P., et al.
Published: (2011-06-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies
by: Chumbita Mariana, et al.
Published: (2024-10-01)

Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine
by: Hradská K, et al.
Published: (2022-05-01)

Management of infectious endocarditis from the perspective of the Infectious Diseases specialist – a 2023 update
by: Oana-Alexandra Ganea, et al.
Published: (2023-03-01)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
by: A.F. Tiburcio Ribeiro, et al.
Published: (2013-02-01)

Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
by: Bernardo Leon Rapoport, et al.
Published: (2018-09-01)

Bundle for the prevention and management of complications of neutropenia in cancer patients
by: Rosilene Aparecida Costa Amaral, et al.

The risk factors for febrile neutropenia during chemotherapy in children with malignancy
by: Rini Sulviani, et al.
Published: (2007-05-01)

The characteristics of side effects of different modes of chemotherapy for breast cancer.
by: I. M. Bondarenko, et al.
Published: (2016-03-01)

The characteristics of side effects of different modes of chemotherapy for breast cancer
by: Bondarenko I.M., et al.
Published: (2016-03-01)

Clinical characteristics and outcomes of <it>Mycobacterium tuberculosis </it>disease in adult patients with hematological malignancies
by: Chen Chien-Yuan, et al.
Published: (2011-11-01)

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia
by: Dessalegn M, et al.
Published: (2023-02-01)

A Retrospective Observational Cohort Analysis of Oncology Patients with Febrile Neutropenia in the Emergency Department of a Tertiary Care Hospital in Oman
by: Badar Al-Aamri, et al.
Published: (2025-01-01)

The efficacy of specific immunocorrection drugs against ovine oestrosis
by: V. A. Marchenko
Published: (2021-09-01)

Chemotherapy limiting neutropenia. Is prevention required?
by: I. B. Kononenko, et al.
Published: (2022-01-01)

Evaluation of the knowledge of hematologists about the management of infectious complications in hematologic patients
by: Mariana Guarana, et al.
Published: (2024-04-01)

Chemotherapy Induced Febrile Neutropenia and Its Association with Nosocomial Bacteraemia: Risk Factors and Prognosis
by: Hadir El-Mahallawy, et al.
Published: (2008-12-01)

BLOOD STREAM INFECTION AMONG THE FEBRILE NEUTROPENIC PATIENTS SUFFER-ING FROM HEMATOLOGICAL DISORDERS AT A TERTIARY CARE CENTRE, NORTH INDIA
by: Munesh Kumar Gupta1, et al.
Published: (2019-03-01)

Evaluation of febrile neutropenic patients hospitalized in a hematology clinic
by: Mücahit Görük, et al.
Published: (2015-12-01)

Evaluating the efficacy of preventive influence of the dietary supplement Vitaglucan with immunocorrective and antioxidant properties in children with frequent acute respiratory infections
by: I.O. Mitiuriaeva-Kornijko, et al.
Published: (2021-10-01)

Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia
by: Sandra Rajme‐López, et al.
Published: (2024-08-01)